Background and Objective: Current treatment technique for laser prostatecto
my involve Nd:YAG wavelength at 60 to 80 W, Use of the KTP wavelength in ad
dition to Nd:YAG allows for vaporization of more tissue, decreasing the amo
unt undergoing coagulation necrosis, In this study, we compared 20 W and 40
W of KTP laser energy in conjunction with the Nd:YAG wavelength for the tr
eatment of benign prostatic hyperplasia (BPH), Patients and Materials: A to
tal of 50 consecutive patients underwent laser ablation of the prostate, wi
th 38 patients (Group I) receiving treatment with 20 W of the KTP and 60 W
of the Nd:YAG wavelengths, The other 12 patients (Group II) underwent treat
ment with 40 W of KTP and 60 W of Nd:YAG laser energy. The patients;had an
initial evaluation consisting of American Urological Association (AUA) Symp
tom Score, uroflowmetry, transrectal ultrasonography for prostate volume me
asurement, and assay of prostate specific antigen (PSA) serum level. The pa
tients were seen in follow-up at 1, 3, and 6 months. Results: The mean symp
tom score decreased from 23.4 to 8.9 from Group I and from 18.2 to 3.5 for
Group II at the 6-month followup. The mean peak urinary flow rate increased
from 8.4 to 15.4 mL/sec Group I and from 8.3 to 16.5 mL/sec in Group II at
the 6-month follow-up, Conclusions: The patients treated with the 40 W of
KTP laser energy experienced a more rapid and sustained improvement in symp
tom score than those treated at 20 W, The improvement in peak urinary flow
rate was approximately the same in the two groups.